A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102

G. K Philips, S Halabi, B. L Sanford, D Bajorin, E. J Small and for the Cancer and Leukemia Group B

Annals of Oncology 20 ( 6 ): 1074 - 1079 , 2009